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Abstract: In the age of evidence based decision making through a systematic review of the literature, statistical meta-analysis has been
extensively used to synthesise published summary data on a particular topic of interest from a number of independent studies in order to
make credible and scientifically valid conclusions. The main objective is to estimate the common effect size as a pooled statistic for any
selected outcome variables from the relevant data. There are several issues concerning the quality and type of the published summary
statistics and inherent heterogeneity among the estimates of the effect size across the studies. This paper covers several estimators of the
common effect size and some of their major impacts in meta-analysis through redistribution of weights to the individual studies. Some
examples from recent literature on cancer research studies are used to illustrate the alternative estimators and discuss their usefulness
in analysing data from randomised controlled trials in medicine.
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1 Introduction
Evidence based decision making is no more limited to
medical and health studies, although it is yet the most
frequently used technique in those fields. It has found its
place in social sciences, education, agriculture, and many
other disciplines. Government departments and
international agencies are increasingly relying on the
evidence based approach to undertake, analyse and
evaluate programs and projects. Systematic reviews are
the key to evidence based decision making. Recently the
daily Guardian of the UK published an example of how
the government is using and emphasising evidence based
decision making (see [1]).
There are obvious advantages of using an evidence
based approach to policy making and many researchers
have come up with valid arguments supporting its
application throughout the policy making cycle. Some of
the key benefits (cf [2]) of using an evidence based
approach to policy making include ensuring that policies
are responding to the real needs of the community,
highlighting the urgency of an issue or problem which
requires immediate attention, sharing of information
amongst other members of the public sector, potentially
reduce government expenditure (which may otherwise be
directed into ineffective policies or programs), and finally
producing an acceptable return on the financial
investment through decisions that are characterised by
transparency and accountability.
The systematic review process ensures that all
relevant studies are considered and properly evaluated to
extract all the information to be used in the evidence
based decision making. A significant part of the
systematic review is the literature review that focuses on
the research problem/topic based on all relevant
publications identified from a search of electronic and
printed sources. The aim is to locate and access all related
materials, critically scrutinise and appraise them to
synthesize all the research evidences relevant to that
topic. Systematic reviews of related published
randomized controlled trials are crucial to evidence based
decision making in medicine and health sciences.
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Evidence based medicine (EBM) is an approach in
medicine that aims to optimize decision-making by
emphasising the use of evidence from well designed and
conducted randomised controlled trials. It uses evidence
from the outcomes of systematic reviews and randomised
controlled trials as opposed to weaker types of results
from research based on case-control and observational
studies. Results obtained by meta-analysis form a crucial
part of many evidence based decisions as it provides
objective and strong evidence based on the published
data. The summary statistics on various outcome
variables are gathered from the published studies as part
of a systematic review of the literature on a topic of
interest. Meta-analysis enables pooling of results of
independent studies on a particular topic. The final pooled
effect size of any relevant outcome variable is taken to be
the results produced by meta-analysis.
2 Systematic Review
In the evidence based decision process the systematic
review of the literature plays a pivotal role. To ensure
coverage of all relevant publications on the topic of
interest for a given period of time extensive search is
conducted on the all available electronic databases,
published journals and conference proceedings in all or
selected languages. The search keywords and phrases
must include all possible combinations and synonyms in
order to capture all studies published. In a medical study
search is also needed on the name of the disease and the
type of treatments in place.
As an example, in a recent study on ”Suture
cruroplasty versus prosthetic hiatal herniorrhaphy for
large hiatal hernia” (cf [7]) extensive searches on
databases such as PubMed, Medline, Embase, Science
Citation Index, Current Contents, and the Cochrane
Central Register of Controlled Trials were conducted. The
search used medical subject headings (MESH); ”hernia,”
”hiatal,” ”hiatus,” ”paraoesophageal/paraesophageal
hernia,” ”laparoscopic repair,” ”comparative study,”
”prospective studies,” ”randomized/randomised
controlled trial,” ”random allocation,” ’clinical trial,” and
”Human”. Furthermore searches were extended to the
bibliographies of all the included primary studies and
existing reviews by hand for additional citations.
Moreover emails to the original authors of some of the
trials were sent for clarification of data and to obtain
unpublished, missing or additional information on various
outcome measures.
2.1 Steps and actions in systematic reviews and
meta-analyses
To ensure the quality of the studies included in the
meta-analysis various steps and procedures were
proposed and are in practice. The Cochrane Handbook
(see [3]) outlines eight general steps for preparing a
systematic review: (1) Defining the review question(s)
and developing criteria for including studies, (2)
Searching for studies, (3) Selecting studies and collecting
data, (4) Assessing risk of bias in included studies, (5)
Analysing data and undertaking meta-analyses, (6)
Addressing reporting biases, (7) Presenting results and
”summary of findings” tables, and (8) Interpreting results
and drawing conclusions.
2.2 Study quality standard
Until recently the common practice was to use the criteria
set by the Quality of Reporting of Meta-analyses
(QUOROM) (cf. [4]) statement to select studies for
meta-analyses. This is now replaced by a more updated
and rigorous set of criteria known as the Preferred
Reporting of Systematic Reviews and Meta-Analyses
(PRISMA) statement (see [5]). There are many quality
scales for studies included in a meta-analysis, and one of
them is the Jadad score (cf. [6]) used to assess the quality
of rendomised controlled trials. The scale ranges from
zero to five, zero being the lowest quality and five being
the highest achievable quality based on reporting of
randomization, blinding, and withdrawals reported during
the study period.
3 Statistical meta-analysis - quantitative
analysis
Meta-analysis is a statistical method used to estimate
combined or common effect size of the outcome variables
in any randomised control trial or independent studies
aiming to estimate the same parameters. The method
provides a scientific mechanism to pool summary
statistics from independent studies and to compute an
estimate of the common effect of interest. The results
from the pooled data of independent studies are used to
make conclusions on the outcome variables. From a
statistical view point, meta-analysis enables incorporation
of summary data from independent studies/trials on the
same topic. The increase in sample size in the
meta-analysis, due to adding a number of studies,
provides much more precise estimate of the common
effect size and increases the power of statistical tests. In
meta-analysis application of appropriate statistical model
for the outcome variables is absolutely essential to reach
the correct conclusion. The choice of a fixed effects
model (FEM) or random effects model (REM) depends
on the assumption that the common effect is fixed or
differs from trial to trial.
In the FE model the inverse of the sample variance is
used as weight in the calculation of the estimate of the
common effect size, and the subsequent confidence
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interval (CI). This leads to higher weights to studies with
more precise outcomes or less spread. Under this model,
larger studies gain higher weight than the smaller studies.
This estimator is inappropriate for heterogeneous studies
as it under estimates the statistical error.
In an attempt to address heterogeneity the RE model
weights are calculated as the inverse of the sum of the
sample variance and the between studies variance.
The recently proposed inverse variance heterogeneity
(IVhet) estimator (see [9]) redistributes weight as with the
FE model. But unlike the FE and RE model based
estimators, the IVhet estimator solves the problem of over
dispersion and is a better estimator than the RE estimator
in terms of mean squared error (MSE) criterion. . Also the
coverage probability of the CI of the common effect size
based on IVhet estimator remains much closer to the
nominal level than that of the RE model estimator.
4 Estimation of common effect size
Statistical meta-analysis uses summary statistics such as
mean and standard deviation of the outcome variables
from the published articles to estimate the common effect
size. The estimation of the common effect size in the
meta-analysis depends on the type of the outcome
variable of interest. For binary (categorical) outcome
variables the point estimate of the effect size is based on
the odds ratio or relative risk or risk ratio, and the related
confidence interval (CI) is based on the sampling
distribution of their logarithm which approximately
normally distributed. A slight adjustment is used for trails
with zero cell counts to avoid division by zero. The
estimation of effect size for the quantitative/continuous
outcome variables is normally based on weighted mean
difference (WMD) when all trials use the same unit of
measurement, and the standardised mean difference
(SMD) when different unit of measurements are used by
different trials. In both cases the CI is constructed based
on the normal distribution of the WMD or SMD.
The forest plot summarises all the numerical results
and represents the confidence intervals of individual
studies as well as the common effect estimate of
meta-analysis with a diamond showing the actual position
of the CI of the relevant mean effect measure. From the
forest plot one could observe any trend towards a
particular intervention as well as finds out if the effect
size is statistically significant. If appropriate subset
analysis is also included in the forest plot to investigate if
there are significant differences of the effect size within
any subset of studies. Often sensitivity analysis is also
undertaken to find out how sensitive the estimate of the
common effect is with respect to one or more studies
included in the meta-analysis.
Another issue in meta-analysis is the publication bias.
This occurs because of selective publication of the
outcomes of the research that favour the sponsor’s
proposition, and ignores the ones with negative or
unfavourable outcomes. To detect publication bias in
meta-analysis funnel plots are used. This plot indicates
presence of publication bias if it demonstrates asymmetry.
4.1 The estimators of common effect
Consider a meta-analysis of k independent studies. Let δ j
be the true effect size of an outcome variable for the jth
study and ˆδ j be its estimate. Let the common or average
effect be θ , and the individual study effects δ1,δ2, . . .δk
depart from θ with random and/or systematic errors.
Furthermore, θ is estimated from the estimated effect size
of the k studies using an empirically weighted mean
estimator ˆθw . This estimator can be quantified in terms of
its difference from the non-empirically weighted
arithmetic mean estimator,
ˆθAM =
1
k
k
∑
j=1
ˆδ j (1)
by the following expression
ˆθw = ˆθAM +
1
k
k
∑
j=1
(
w j −
1
k
)(
ˆδ j − ˆθAM
)
= ˆθAM + kρw ˆδ σwσ ˆδ (2)
where σ
ˆδ and σw are the standard deviation of ˆδ j and the
weights, and ρ
w ˆδ is the coefficient of correlation between
the weights and the effect estimates. For the FE model, the
weighted inverse variance estimator,
ˆθIV het =
1
k
k
∑
j=1
w j ˆδ j (3)
has weights
w j =
1
v j
∑kj=1 1v j
(4)
where w j sums to 1, and the sampling error variance of
the estimator of the jth study is v j . The arithmetic mean
estimator, as in (1) is unbiased. But, is a biased estimator.
However, the FE estimator does improve over the
arithmetic mean estimator because the weights don’t just
increase the bias, but (by doing so) they also make the
variance of the estimator much smaller and trade off this
bias.
Under the RE model the weighted estimator is defined
as
ˆθRE =
1
k
k
∑
j=1
w∗j ˆδ j (5)
where the weights are
w∗j =
1
σ 2j
∑kj=1 1σ 2j
(6)
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Table 1: Summary of the three alternative estimators of the
common effect size
IVhet RE AMhet
Weight w j =
1
v j
∑kj=1 1v j
w∗j =
1
σ2j
∑kj=1 1σ2j
1
k
Estimator ˆθIV het =
∑kj=1 w j ˆδ j
k
ˆθRE =
∑kj=1 w∗j ˆδ j
k
ˆθAM = 1k ∑kj=1 ˆδ j
Variance ∑kj=1 w2j(v j + τ2) 1∑kj=1 1σ2j
∑kj=1 v j+τ
2
k2
Table 2: Summary of all the RCTs included in the study
Authors Year/Country Type of Study Number of Patients 
   D1 D2 
Dent et al 1988/ South Africa RCT 22 21 
Robertson et al
 
1994/ Hong Kong RCT 25 29 
Bonenkamp et al
 
1995/ Netherlands RCT 513 483 
Cuschieri et al
 
1999/ UK RCT 200 200 
Degiuli et al
 
2004/ Italy RCT 76 86 
Chew-Wun Wu et al
 
2006/ Taiwan RCT 110 111 
Total   946 930 
 
Table 3: Summary statistics of the outcome variables under RE
model
Outcome Variables Pooled OR 
or WMD (95% CI) 
Test for overall effect Test for heterogeneity 
  Z p-value Q p-value I^2 Index 
Length of hospital stay -5.67 (-9.83, -1.51) -2.56 0.01 36.34 0.0001 86.2% [72.2%; 93.2%] 
Complication rate 0.42 (0.27, 0.66) 4.33 0 11.85 0.0369 57.8% [0%; 82.9%] 
Anastomotic leak rate 0.40 (0.25, 0.63) 4.13 0 1.72 0.8868 0% [0%; 26.1%] 
Re-operation rate 0.33 (0.15, 0.72) 2.23 0.023 3.52 0.3179 14.8% [0%; 87%] 
30-day mortality rate 0.59 (0.40, 0.85) 5.14 0 1.86 0.8684 0% [0%; 31.7%] 
5-year survival rate 0.97 (0.78; 1.20) 9.03 0 1.67 0.797 0% [0%; 50.1%] 
 
with σ2j = v j + τ2 in which v j is the sampling error
variance and τ2 is a moment-based estimate of the
between-studies variance, which is assumed to be a
constant for each study. The variance of any weighted
estimator is given by
var( ˆθw) =
k
∑
j=1
w2jvar( ˆδ j) (7)
where w j’s are the weights that sum to 1. Table 1 provides
the three different estimators along with their weights and
variances.
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Fig. 1: Forest plot of length of hospital stay under RE (top) and
IVhet models (LHS favours D1)
4.2 Heterogeneity issue
The heterogeneity of the estimated effect size for different
studies is often a major issue in meta-analysis. The
obvious reason for heterogeneity is the sampling
error/variation due to random causes. But in case of the
independent RCTs there is additional variation due to the
differences in the quality of the trials such as the hospital
environment, surgeon, equipment etc and the associated
bias. These non-random variation makes significant
impact on the overall spread of the estimator of common
effect size causing significant heterogeneity as shown in
Doi et al. [8].
As a routine procedure the heterogeneity among the
estimated effect size of outcome variables of different
studies is assessed using the Cochran’s Q and I2 statistics.
The p-value of the test indicates the plausibility of the
null hypothesis (of homogeneity of mean effects), given
the observed data. Thus for a very small p-value (usually
less than 5%) the hypothesis of equality of the variances
of mean effects is rejected. As a consequence researchers
are required to use appropriate method of estimation to
overcome the problem of heterogeneity. The current
choice is to use the RE model, but alternative methods
such as the IVhet method should be encouraged given the
flaws with the RE method. The RE model allows for an
extra between-study variation in estimating the common
c© 2016 NSP
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Fig. 2: Forest plot of operation complications under RE (top) and
IVhet models (LHS favours D1)
effect. But there have been many criticisms of the RE
method due to its inappropriate distribution of weights
with effectively smaller weights for larger studies and
higher weights for smaller studies. Another better
alternative the quality effect (QE) model has also been
proposed by Doi and Thalib [10], and an implementation
platform MetaXL has been created by Barendregt and
Doi [12] as an add-on to MS Excel that is free of charges.
Further details on quality effect model see Doi and Thalib
[11]. This method has been refreshed by Doi et al. [8].
4.3 Mean and median issue
Normally published studies use mean and standard
deviation as summary measures for centre and spread of
common outcome variables. However, in some studies
median and interquartile range (IQR) are reported for the
same measures. In other studies the minimum, maximum,
IQR, and range are used. Unfortunately, meta-analysis
method could only use the mean and standard deviation.
If the distribution of the outcome variable is
approximately symmetrical, the median is no different
from the mean, but in case of skewed distribution the
issue becomes serious. Hozo et al. [13] provides some
useful conversion formula to mean and standard deviation
from median and other summary statistics. Sometimes the
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Fig. 3: Forest plot of anastomotic leak under RE (top) and IVhet
models (LHS favours D1)
authors of the published paper are helpful to access the
appropriate summary statistics via email or any other
mode of communication.
5 Meta-analysis in a cancer research study
The statistical meta-analysis has been applied in many
different fields in recent years. But no other discipline has
used it more than medical and health sciences. There are
many meta-analyses in the literature in the area of cancer
research and randomised controlled trials (RCTs) on
various surgical procedures in cancer treatment.
Recently Memon et al. [14] conducted a
meta-analysis of randomized controlled trials to evaluate
the efficacy and drawbacks of limited (D1) versus
extended lymphadenectomy (D2) for proven gastric
adenocarcinoma based on the studies published from
1988 to 2006 using RE model. We consider the data from
the same six RCTs to produce meta-analysis using the
IVhet estimator and compare it with the RE model
estimator using the MetaXL package. Each of the six
independent studies reported on six outcome variables,
namely (1) length of hospital stay, (2) complication rate,
(3) anastomotic leak rate, (4) re-operation rate, (5) 30-day
mortality rate, and (6) 5-year survival rate.
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5.1 Forest plots
Forest plots draw the 95% confidence intervals for the
common effect size such as (log) odds ratios, or weighted
mean differences (WMD) as horizontal lines. Confidence
intervals show arrows when they exceed specified limits.
In the forest plot, a square indicates the estimated
treatment effect with the size of the square representing
the weight attributed to the relevant study. The pooled
estimated (log) OR/WMD is obtained by combining (log)
ORs/WMDs of all the studies using the two methods. The
pooled common effect is represented by the diamond and
the width of the diamond depicts the 95% confidence
interval. For the binary outcomes the null (log) OR line is
drawn at zero or for OR at one, and for the continuous
outcomes, the null WMD line is drawn at zero. The forest
plots for the six outcome variables of the randomised
controlled trials to evaluate the efficacy and drawbacks of
limited (D1) versus extended (D2) lymphadenectomy for
proven gastric adenocarcinoma are given in Figures 1-6.
5.2 Funnel plots for publication bias
Funnel plots represent the scatterplot of the log odds
ratios or WMDs against their standard errors. A funnel
plot of standard error versus treatment effect from
individual studies in a meta-analysis should look like a
symmetrical inverted funnel if there is no publication
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Fig. 5: Forest plot of mortality under RE (top) and IVhet models
(LHS favours D1)
bias. Points falling to one side of the funnel indicate
presence of publication bias. Funnel plots for the outcome
variables of the study to evaluate the efficacy and
drawbacks of limited (D1) versus extended (D2)
lymphadenectomy for proven gastric adenocarcinoma are
given in Figures 7-11.
6 Results and conclusions
In the six trials there were a total of 1876 patients
(D1 = 946, D2 = 930). The meta-analysis of the six
outcome variables shows all of them favoured D1 over D2
group. Under the RE model there is a statistically
significant reduction of (i) 5.67 days in hospital stay
(WMD -5.67, CI -9.83, -1.15, p = 0.01), and only 3.56
days under IVhet model, which is insignificant, with
(WMD -3.56, CI -8.19, 1.06, p = 0.13); (ii) 58%
reduction in relative odds of developing postoperative
complications (OR 0.42, CI 0.27, 0.66, p = 0.0002) under
RE model, and 52% reduction (OR 0.48, CI 0.28, 0.82,
p < 0.001) under IVhet model; (iii) 60% reduction in
anastomotic breakdown (OR 0.40, CI 0.25, 0.63,
p = 0.0001) under RE model, and the same under IVhet
model (since the I2 = 0); (iv) 67% reduction in
re-operation odds (OR 0.33, CI 0.15, 0.72, p = 0.006)
under RE model, and 59% reduction under IVhet model
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Fig. 6: Forest plot of five-year survival time under RE (top) and
IVhet models (LHS favours D1)
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Fig. 7: Funnel plot of post operation complications
with (OR 0.41, CI 0.17, 0.95, p = 0.04) ; (v) 41%
reduction in 30-day mortality odds (OR 0.59, CI 0.40,
0.85, p = 0.0054) under RE model, and the same for the
IVhet model (as I2 = 0); and only 3% reduction in the
odds of 5-year survival (OR 0.97, CI 0.78, 1.20) in D1
over D2 gastrectomy patients under both models.
Based on this meta-analysis under the RE model we
conclude that D1 gastrectomy is associated with
significant fewer anastomotic leaks, postoperative
complication rate, re-operation rate, decreased length of
hospital stay, less 30-day mortality rate, and the 5-year
survival in D1 gastrectomy patients compared to the D2
cohort. The conclusions on the estimate of the common
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Fig. 8: Funnel plot of anastomotic leak
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Fig. 9: Funnel plot of re-operation
Mortality
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Fig. 10: Funnel plot of mortality
effect for the outcome variables anastomotic leak,
mortality and five year survival are the same under both
the models. This is because there is no significant
variation (heterogeneity) among the studies. For the other
three outcome variables there are some differences in the
estimate of the common effect size. For the analysis under
the IVhet model, there is slightly less reduction of
number of days (3.56 under IVhet vs 5.67 under RE) of
hospital stay, slightly less reduction in postoperative
complications (52% under IVhet vs 58% under RE) and
re-operation rate (59% under IVhet vs 67% under RE).
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Fig. 11: Funnel plot of five-year survival
Overall the D1 limited surgery is supported by the data
over its competitor D2 extended surgery for all the
outcome variables under both the models. Given the
problems with the RE method, we conclude it under
estimated the statistical error with hospital stay leading to
a spuriously significant result.
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